Giv′at-Shmuel, Israel

Yehonathan Pouny

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 6.9

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2007-2015

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yehonathan Pouny: Innovator in Polypeptide Research

Introduction

Yehonathan Pouny is a notable inventor based in Giv′at-Shmuel, Israel. He has made significant contributions to the field of polypeptide research, holding 2 patents that showcase his innovative work. His research focuses on the development of polypeptides with unique properties and applications.

Latest Patents

Pouny's latest patents include "Sp1 polypeptides, modified Sp1 polypeptides and uses thereof" and "Denaturant stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof." The first patent describes SP1 and modified SP1 variant polypeptides capable of forming reversible molecular associations with various substances. The second patent introduces novel denaturant-stable, protease-resistant, homo-oligomeric proteins, which have chaperone-like activity. These innovations have potential applications in stabilizing and repairing macromolecules such as proteins.

Career Highlights

Throughout his career, Yehonathan Pouny has worked with esteemed organizations, including Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. and Fulcrum Sp Ltd. His work in these companies has allowed him to advance his research and contribute to the scientific community.

Collaborations

Pouny has collaborated with notable colleagues, including Ira Marton and Amnon Wolf. These partnerships have enriched his research and expanded the impact of his inventions.

Conclusion

Yehonathan Pouny is a distinguished inventor whose work in polypeptide research has led to significant advancements in the field. His innovative patents and collaborations highlight his commitment to scientific progress and the development of new technologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…